Unlock instant, AI-driven research and patent intelligence for your innovation.

Fusion proteins comprising carriers that can induce a dual immune response

a technology of fusion proteins and carriers, applied in the field of animal and human health, can solve the problems of inability to mount an effective antibody response against gnrh, weak immunogenicity, and inability to induce an effective immune response of animals, and achieve the effect of protecting vertebrate cells and inhibiting the activity of peptides

Inactive Publication Date: 2005-05-05
CAMPOS MANUEL +3
View PDF31 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0009] The subject invention provides a fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises: (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate; connected to (b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate; the portion (b) causing the vertebrate's immune system to recognize the portion (a) and produce a response that: (i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and (ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein.

Problems solved by technology

Certain molecules, however, comprise epitopes which do not induce an effective immune response in a vertebrate because of their small size and / or because they are endogenously synthesized within the vertebrate and are therefore not perceived as “foreign” by the vertebrate's immune system.
However, since GnRH is a small self peptide and has a short half-life (WO 90 / 02187, Mar. 8, 1990), it is only weakly immunogenic, even when injected with a powerful adjuvant.
For example, a significant proportion of animals are not able to mount an effective antibody response against GnRH when administered in Freund's complete adjuvant.
None of the aforementioned references, however, teach or suggest using a carrier which triggers an immunoinhibiting response against itself.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fusion proteins comprising carriers that can induce a dual immune response
  • Fusion proteins comprising carriers that can induce a dual immune response
  • Fusion proteins comprising carriers that can induce a dual immune response

Examples

Experimental program
Comparison scheme
Effect test

example 1

Plasmids Expressing gD / GnRH Fusion Proteins

[0133] Construction of pQE-tmgD: The plasmid FlgD / Pots207nco(#79) (encoding a full-length gD, hereinafter “gD / Pots”) was digested with NcoI / XbaI and the resulting 1.26 kb fragment was cloned into the corresponding sites of pUC21, generating the plasmid pUC-FLgD. The complete sequence of the NcoI / XbaI fragment in the plasmid pUC-FLgD was determined on both DNA strands using Sanger fluorescent dideoxy chain termination sequencing technology. FIG. 3 shows the sequence results and characteristics. The nucleotide sequence encoding gD / Pots is included in SEQ ID NO: 16.

[0134] DNA alignment between gD / Pots and published BHV-IgD (GenBank Accession No. M59846) shows 94.7% homology with the majority of the mismatches occurring 3′ of the transmembrane domain (FIG. 4).

[0135] Amino acid alignment between gD / Pots and M59846 shows four amino acid differences, one of which is located in the signal sequence and the other three in or around the transmembra...

example 2

Expression of GnRH / gD Fusion Proteins by Transformed Bacterial Cells

[0156] All of the pQE constructs described in Example 1, above, were transformed into E. coli DH5α-F′IQ cells for expression. For induction of expression, cells were grown to an OD600 of 0.7-0.9 in a 2 liter baffled culture flask in 2xYT broth containing 100 μg / ml Ampicillin and 25 μg / ml Kanamycin, then induced with 1-2 mM IPTG and incubated for 4 hours at 37 degrees Celsius. Average OD600 readings at harvest time were 1.3. Expression of all four constructs was confirmed by Western blot analysis.

example 3

Formulation of Fusion Protein Vaccines and Immunization of Mice

[0157] Vaccine Assembly: Fusion proteins from pQE-tmgD (as a control), pQE-GnRH:gD, pQE-GnRH:gD:GnRH, and pQE-gD:GnRH were concentrated from inclusion body preparations by preparative electrophoresis on 9% polyacrylamide gels. Bands cut from SDS PAGE gels were dissolved in 25 mM Tris, pH 8.3, 192 mM glycine and 0.1% SDS (w / v). The equivalent of 10%1 g gD / mouse dose was adjuvanted with SEAM1 (Squalene Emulsion Adjuvant Metabolizable) emulsion (10 μg QuilA / 100 μl dose). Vaccine formulations were stored at 4° C. SEAM1 is 5% squalene, 0.1% Vitamin E acetate, 1% Span 85, 0.70% Tween 80, 2 mg / ml QuilA, and 400 μl / ml cholesterol.

[0158] Mice: BALB / c males were used in the study after they were 8 weeks of age (10 / group). Mice were initially housed in groups of 10, however, controls were subsequently moved to individual cages to prevent fighting.

[0159] Immunization: Mice were immunized subcutaneously with 10 μg fusion protein i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The subject invention provides a fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises: (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate; connected to (b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate; the portion (b) causing the vertebrate's immune system to recognize the portion (a) and produce a response that: (i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and (ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein. The subject invention also provides fusion proteins which comprise a proteinaceous portion (b) that is a carrier that is analogous to all or part of a BHV-1 antigen, which fusion proteins induce in a vertebrate vaccinated with an effective amount of such fusion protein an immune response that inhibits the activity of a peptide as recited in (a), above.

Description

FIELD OF THE INVENTION [0001] The present invention is in the field of animal and human health, and is directed to fusion proteins useful in vaccine compositions. BACKGROUND OF THE INVENTION [0002] The vertebrate immune system comprises an intricate system of cells, secreted factors, and responses for protecting an organism from pathogenic infection by microbes, viruses, toxins, and other pathogens and irritants. Certain molecules, however, comprise epitopes which do not induce an effective immune response in a vertebrate because of their small size and / or because they are endogenously synthesized within the vertebrate and are therefore not perceived as “foreign” by the vertebrate's immune system. Methods for producing antibodies against certain peptides which are normally non-immunogenic, such as hormones, are desirable because immunoregulation of the activity of such peptides within the organism can thereby be achieved. [0003] Hormone peptides have been combined with various carri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/09A61K38/00A61K39/00A61K39/21A61K39/245A61K39/385A61P31/22C07K7/23C07K14/03C07K16/26C07K19/00C12N1/15C12N1/19C12N1/21C12N5/10C12N15/62C12N15/70C12N15/79G01N33/566
CPCA61K38/00A61K39/00A61K39/0006C07K7/23C12N2710/16722C07K16/26C07K19/00C07K2319/00C07K14/005A61P31/22
Inventor CAMPOS, MANUELYULE, TERECITAMARTINOD, SERGEDURTSCHI, BECKY
Owner CAMPOS MANUEL